Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →BLRD VA
Grant: I01 BX005260
NCI NIH HHS
Grant: R25 CA214272
National Institutes of Health
Grant: 5R25CA214272-04
Increasing Diversity in Undergraduate Cancer Biology Education and Research (INDUCER)
US Department of Veterans Affairs
National Cancer Institute
FWCI
2.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals